--- title: "Precision for Medicine opens Singapore office, expanding APAC presence to 7 locations, offering local expertise and global scale." type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/274987990.md" description: "Precision for Medicine (Precision), a renowned player in biomarker-driven clinical research and development, has extended its APAC presence to seven locations with the inauguration of an office in Singapore. The move aims to combine local expertise with global scale. The news was disclosed on Feb. 5, 2026, in Bethesda, Md. The expansion signifies an enhanced effort to cater to the Asia-Pacific region's vibrant market, indicating significant growth and diversification for Precision." datetime: "2026-02-05T13:53:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/274987990.md) - [en](https://longbridge.com/en/news/274987990.md) - [zh-HK](https://longbridge.com/zh-HK/news/274987990.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/274987990.md) | [English](https://longbridge.com/en/news/274987990.md) # Precision for Medicine opens Singapore office, expanding APAC presence to 7 locations, offering local expertise and global scale. Precision for Medicine (Precision), a renowned player in biomarker-driven clinical research and development, has extended its APAC presence to seven locations with the inauguration of an office in Singapore. The move aims to combine local expertise with global scale. The news was disclosed on Feb. 5, 2026, in Bethesda, Md. The expansion signifies an enhanced effort to cater to the Asia-Pacific region's vibrant market, indicating significant growth and diversification for Precision. ### 相關股票 - [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md) - [iShares Global Healthcare (IXJ.US)](https://longbridge.com/zh-HK/quote/IXJ.US.md) - [Minsheng Royal CSI Biotechnology Theme ETF (516930.CN)](https://longbridge.com/zh-HK/quote/516930.CN.md) - [Founder Fubon CSI Medicine and Medical Device Innovation ETF (560600.CN)](https://longbridge.com/zh-HK/quote/560600.CN.md) - [Catheter Precision (VTAK.US)](https://longbridge.com/zh-HK/quote/VTAK.US.md) - [Penghua SSE STAR Biology and Medicine ETF (588250.CN)](https://longbridge.com/zh-HK/quote/588250.CN.md) - [E Fund CSI Biotechnology Theme ETF (159837.CN)](https://longbridge.com/zh-HK/quote/159837.CN.md) - [ChinaAMC CSI Biotechnology Theme ETF (516500.CN)](https://longbridge.com/zh-HK/quote/516500.CN.md) - [SPDR S&P Health Equip (XHE.US)](https://longbridge.com/zh-HK/quote/XHE.US.md) - [Penghua CSI HK Connect Health Care Composite ETF (513700.CN)](https://longbridge.com/zh-HK/quote/513700.CN.md) - [ChinaAMC SSE Health Care ETF Initiating Fund (510660.CN)](https://longbridge.com/zh-HK/quote/510660.CN.md) - [Guotai CSI Bio-medicine ETF (512290.CN)](https://longbridge.com/zh-HK/quote/512290.CN.md) - [Prime Medicine (PRME.US)](https://longbridge.com/zh-HK/quote/PRME.US.md) - [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md) - [ChinaAMC SSE STAR Biology and Medicine ETF (588130.CN)](https://longbridge.com/zh-HK/quote/588130.CN.md) - [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md) - [Praxis Precision Medicines (PRAX.US)](https://longbridge.com/zh-HK/quote/PRAX.US.md) - [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md) - [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md) - [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md) - [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md) - [Huaan Hang Seng Biotech ETF (159102.CN)](https://longbridge.com/zh-HK/quote/159102.CN.md) - [China Merchants CSI All Share Medical Apparatus and Instruments ETF (159898.CN)](https://longbridge.com/zh-HK/quote/159898.CN.md) - [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md) - [ICBCCS SSE STAR Biology and Medicine ETF (588860.CN)](https://longbridge.com/zh-HK/quote/588860.CN.md) - [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md) - [Ping An CSI Medicine and Medical Device Innovation ETF (516820.CN)](https://longbridge.com/zh-HK/quote/516820.CN.md) - [iShares US Medical Devices (IHI.US)](https://longbridge.com/zh-HK/quote/IHI.US.md) - [ChinaAMC CSI All Share Health Care Devices ETF (562600.CN)](https://longbridge.com/zh-HK/quote/562600.CN.md) - [Maxwealth CSI All Share Medical Apparatus and Instruments ETF (159883.CN)](https://longbridge.com/zh-HK/quote/159883.CN.md) - [E Fund CSI 300 Health Care ETF (512010.CN)](https://longbridge.com/zh-HK/quote/512010.CN.md) - [CS精准医 (000863.CN)](https://longbridge.com/zh-HK/quote/000863.CN.md) - [E Fund Hang Seng SCHK Innovative Drug ETF (159316.CN)](https://longbridge.com/zh-HK/quote/159316.CN.md) - [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md) - [Tianhong CNI BIOMEDICINE ETF (159859.CN)](https://longbridge.com/zh-HK/quote/159859.CN.md) - [Hwabao WP CSI Pharmaceuticals ETF (562050.CN)](https://longbridge.com/zh-HK/quote/562050.CN.md) - [Yinhua CSI Innovative Drugs Industry ETF (159992.CN)](https://longbridge.com/zh-HK/quote/159992.CN.md) - [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md) - [China Merchants CSI Biotechnology Theme ETF (159849.CN)](https://longbridge.com/zh-HK/quote/159849.CN.md) ## 相關資訊與研究 - [Profound Medical Showcases TULSA-PRO at Key Radiology Meeting](https://longbridge.com/zh-HK/news/281391648.md) - [11:36 ETAZCOMP Technologies Earns CGM Reseller of the Year Award](https://longbridge.com/zh-HK/news/281549899.md) - [Revolution Medicines' Readout of Trial for Pancreatic Cancer Drug Likely Positive, Oppenheimer Says](https://longbridge.com/zh-HK/news/281049250.md) - [Vertex Pharmaceuticals Says US FDA Approves Label Expansion for Alyftrek, Trikafta](https://longbridge.com/zh-HK/news/281365753.md) - [Zymewire Releases 2025 Annual Biopharma Recap, Expanding Proprietary Intelligence with Exclusive Industry Content](https://longbridge.com/zh-HK/news/281399847.md)